Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs|
Thursday, March 10, 2011
New U.S. patent adds to four others received over last six months.
Metabolomics Study Provides Insight into Glioma-Associated Metabolic Changes
Friday, March 04, 2011
Application of metabolomics to mutant IDH1- and IDH2-expressing HOG cells revealed altered metabolism in the cells and provided clues to the pathogenesis of tumors.
DiaMedica Announces Positive Results from a Hypertension Study With its GSK3B-Blocking Antibody
Thursday, March 03, 2011
DiaMedica announces antihypertensive results with antibody DM-204.
Identifying microRNAs that can Serve as Biomarkers for Prostate Cancer
Wednesday, February 23, 2011
UCSF researchers identify serum microRNAs by using Fluidigm Corporation's BioMark™ System and Digital Array™ IFCs.
Bruker Installs NMR Metabolic Profiling Systems at NTNU Trondheim for Research on Cancer Diagnostics and Treatment
Wednesday, February 16, 2011
Researchers will use the NMR instrumentation for rapid, high-throughput analyses, aiming for characterization, treatment planning and monitoring of cancer patients.
BD Launches World’s Smallest Pen Needle
Friday, February 11, 2011
BD announces the launch of BD Micro-Fine™+ 4mm pen needle - the world’s smallest pen needle. This needle is proven to be as effective as longer needles for patients of all body types and proven to offer a less painful injection experience for the estimated 800,000 people in the UK with diabetes using injectable therapies.
Highly Efficient, Reproducible Non-Cytotoxic Transfection Reagent
Saturday, January 15, 2011
GenePORTER® Gold from AMSBIO is a reproducible lipid-based reagent for effective transfection of a wide variety of cell lines.
Sera Lab Launches Extensive Microsome and S9 Fraction Range for Drug Metabolism Studies
Thursday, December 09, 2010
Broad range of liver microsomes enables advanced drug development research.
Biotivia Release Resveratrol Related Supplement, Pteromax
Friday, December 03, 2010
Research studies of pterostilbene have shown stronger effects in the reduction of cholesterol and improvement of cognitive function.